title: Propagation of alloreactive lymphocytes from histologically negative endomyocardial biopsies from heart transplant patients. Association with subsequent histological evidence of allograft rejection.
abstract: Endomyocardial biopsies from heart transplant patients were cultured in vitro in the presence of Interleukin-2 and irradiated feeder cells to propagate graft-infiltrating lymphocytes. A correlation was seen between the frequency of lymphocyte growth and the degree of cellular infiltration of the biopsies. In this study, 43 of 113 (38%) histologically negative biopsies obtained from 55 patients during the first month post-transplant yielded lymphocyte cultures. The cumulative incidence of subsequent histological rejection was considerably higher in patients with such "grower" biopsies than in patients with "nongrower" biopsies. In the grower group, we were able to obtain data on alloreactivity of 32 lymphocyte cultures assayed by primed lymphocyte testing (PLT). The presence of donor-specific PLT reactivity in the cultured lymphocytes was associated with an additional risk for subsequent histological rejection. These findings suggest that the in vitro culturing of histologically negative endomyocardial biopsies will identify patients at increased risk for developing heart transplant rejection.
authors.affiliation: Department of Pathology, University of Pittsburgh, Pennsylvania 15213.
authors.forename: T
authors.initials: T
authors.lastname: Weber
authors.forename: T
authors.initials: T
authors.lastname: Zerbe
authors.forename: C
authors.initials: C
authors.lastname: Kaufman
authors.forename: A
authors.initials: A
authors.lastname: Zeevi
authors.forename: R
authors.initials: R
authors.lastname: Kormos
authors.forename: R
authors.initials: R
authors.lastname: Hardesty
authors.forename: B
authors.initials: B
authors.lastname: Griffith
authors.forename: R J
authors.initials: RJ
authors.lastname: Duquesnoy
mesh_terms: D001706:Biopsy; D002478:Cells, Cultured; D006084:Graft Rejection; D016027:Heart Transplantation; D006801:Humans; D007111:Immunity, Cellular; D007376:Interleukin-2 / Q000494:pharmacology; D008213:Lymphocyte Activation; D008214:Lymphocytes / Q000276:immunology*; D009206:Myocardium / Q000276:immunology* / Q000473:pathology; D013997:Time Factors
chemical_list: D007376:Interleukin-2